sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate

C43H46Cl2N10NaO7S+ — CID 157138552

IUPACsodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate
SMILESO.O=C(O)CCC(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.O=C(O)CCS(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.[Na+]
InChIInChI=1S/C22H22ClN5O3.C21H22ClN5O3S.Na.H2O/c23-17-3-1-16(2-4-17)21-20(15-7-9-24-10-8-15)22(26-25-21)28-13-11-27(12-14-28)18(29)5-6-19(30)31;22-17-3-1-16(2-4-17)20-19(15-5-8-23-9-6-15)21(25-24-20)26-10-12-27(13-11-26)31(30)14-7-18(28)29;;/h1-4,7-10H,5-6,11-14H2,(H,25,26)(H,30,31);1-6,8-9H,7,10-14H2,(H,24,25)(H,28,29);;1H2/q;;+1;
InChIKeyPIDRGHHWYHPOKH-UHFFFAOYSA-N
MW940.87 g/mol
LogP2.54
Rot. Bonds13

About sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate

sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate (PubChem CID 157138552) has the molecular formula C43H46Cl2N10NaO7S+ and a molecular weight of 940.87 g/mol. Its IUPAC name is sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate.

Molecular Properties

Compound Namesodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate
PubChem CID157138552
Molecular FormulaC43H46Cl2N10NaO7S+
Molecular Weight940.87 g/mol
Exact Mass939.25
IUPAC Namesodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate
SMILESO.O=C(O)CCC(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.O=C(O)CCS(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.[Na+]
InChIInChI=1S/C22H22ClN5O3.C21H22ClN5O3S.Na.H2O/c23-17-3-1-16(2-4-17)21-20(15-7-9-24-10-8-15)22(26-25-21)28-13-11-27(12-14-28)18(29)5-6-19(30)31;22-17-3-1-16(2-4-17)20-19(15-5-8-23-9-6-15)21(25-24-20)26-10-12-27(13-11-26)31(30)14-7-18(28)29;;/h1-4,7-10H,5-6,11-14H2,(H,25,26)(H,30,31);1-6,8-9H,7,10-14H2,(H,24,25)(H,28,29);;1H2/q;;+1;
InChIKeyPIDRGHHWYHPOKH-UHFFFAOYSA-N
XLogP2.54
TPSA236.34 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms64
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500940.87
LogP ≤ 52.54
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate?
The IUPAC name of sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate (CID 157138552) is sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate.
What is the SMILES notation for sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate?
The canonical SMILES for sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate is O.O=C(O)CCC(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.O=C(O)CCS(=O)N1CCN(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1.[Na+].
What is the InChIKey of sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate?
The InChIKey is PIDRGHHWYHPOKH-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H22ClN5O3.C21H22ClN5O3S.Na.H2O/c23-17-3-1-16(2-4-17)21-20(15-7-9-24-10-8-15)22(26-25-21)28-13-11-27(12-14-28)18(29)5-6-19(30)31;22-17-3-1-16(2-4-17)20-19(15-5-8-23-9-6-15)21(25-24-20)26-10-12-27(13-11-26)31(30)14-7-18(28)29;;/h1-4,7-10H,5-6,11-14H2,(H,25,26)(H,30,31);1-6,8-9H,7,10-14H2,(H,24,25)(H,28,29);;1H2/q;;+1;.
What are the key properties of sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate?
sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate has a molecular weight of 940.87 g/mol, XLogP of 2.54, 13 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;4-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]-4-oxobutanoic acid;3-[4-[5-(4-chlorophenyl)-4-pyridin-4-yl-1H-pyrazol-3-yl]piperazin-1-yl]sulfinylpropanoic acid;hydrate is sourced from PubChem (CID 157138552), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).